MedTrace Logo

The Effectiveness of Non-Invasive Ventilation Use in Preterm Infants.

NCT02628821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-08-27

No results posted yet for this study

Summary

Prospective observational study of SNIPPV use in preterm infants of less than 32weeks of gestation from January 2012 to December 2015. Previous respiratory status is analyzed as well as respiratory outcomes and possible secondary side effects.

SNIPPV is used to prevent Intubation in Infants in which nCPAP has already failed (Infants that met intubation criteria) and also is used electively for extubation when nCPAP extubation has previously failed or infants with Prolonged mechanical ventilation (more than 15 days) with high respiratory parameters (PMAP \> 10 cmH2O and FiO2\>35%).

Conditions

  • Noninvasive Ventilation
  • Preterm Infants

Interventions

OTHER

Preterm Infants treated with non-invasive ventilation.

Sponsors & Collaborators

  • Hospital General Universitario Gregorio Marañon

    lead OTHER

Principal Investigators

  • Cristina Ramos-Navarro · Gregorio Marañón Hospital

Eligibility

Min Age
1 Minute
Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02628821 on ClinicalTrials.gov